TY - JOUR
T1 - Association of immune-mediated necrotizing myopathy with HLA polymorphisms
AU - Ohnuki, Yuko
AU - Suzuki, Shigeaki
AU - Uruha, Akinori
AU - Oyama, Munenori
AU - Suzuki, Shingo
AU - Kulski, Jerzy K.
AU - Nishino, Ichizo
AU - Shiina, Takashi
N1 - Funding Information:
The Japanese Ministries of Education, Culture, Sports, Science and Technology, Grant/Award Number: 22133002; Intramural Research Grant (2‐5, 29‐4) for Neurological and Psychiatric Disorders of NCNP Funding information
Funding Information:
This work was supported partly by grants from the Japanese Ministries of Education, Culture, Sports, Science and Technology (MEXT KAKENHI Grant Number 22133002) and partly by Intramural Research Grant (2–5) for Neurological and Psychiatric Disorders of NCNP.
Publisher Copyright:
© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
PY - 2023/5
Y1 - 2023/5
N2 - Immune-mediated necrotizing myopathy (IMNM) is a type of autoimmune myositis typically characterized clinically by proximal muscle weakness with elevated creatine kinase levels, pathologically by myofiber necrosis and regeneration with paucity of lymphocytic cell infiltration, and serologically by the presence of either of two myositis-specific autoantibodies, anti-SRP, and anti-HMGCR antibodies. However, the HLA loci and alleles associated with IMNM are still not fully understood at least partly because IMNM was a relatively recently established condition. In this study, we genotyped the six HLA loci (HLA-A, -B, -C, -DRB1, -DQB1 and -DPB1) in 250 patients (237 patients over age 18 years and 13 juvenile patients) diagnosed with IMNM based on clinicopathological features and autoantibody information and performed a case control study with Japanese healthy subjects. In the adult patients, specific HLA alleles associated with IMNM were identified at all HLA loci, with DRB1*08:03 showing the strongest association (OR = 2.5; p = 0.00000017). Furthermore, subgroup analysis with various clinical information showed that C*03:04 (OR = 3.7; p = 0.00012) was a higher risk allele for collagen disease in adult patients, and B*13:01 (OR = 23.2; p = 0.021) and C*03:04 (OR = 5.8; p = 0.0074) were higher risk for juvenile patients with anti-HMGCR antibody-positive IMNM. These findings will help to better understand the HLA genetic background and features of IMNM in designing future studies.
AB - Immune-mediated necrotizing myopathy (IMNM) is a type of autoimmune myositis typically characterized clinically by proximal muscle weakness with elevated creatine kinase levels, pathologically by myofiber necrosis and regeneration with paucity of lymphocytic cell infiltration, and serologically by the presence of either of two myositis-specific autoantibodies, anti-SRP, and anti-HMGCR antibodies. However, the HLA loci and alleles associated with IMNM are still not fully understood at least partly because IMNM was a relatively recently established condition. In this study, we genotyped the six HLA loci (HLA-A, -B, -C, -DRB1, -DQB1 and -DPB1) in 250 patients (237 patients over age 18 years and 13 juvenile patients) diagnosed with IMNM based on clinicopathological features and autoantibody information and performed a case control study with Japanese healthy subjects. In the adult patients, specific HLA alleles associated with IMNM were identified at all HLA loci, with DRB1*08:03 showing the strongest association (OR = 2.5; p = 0.00000017). Furthermore, subgroup analysis with various clinical information showed that C*03:04 (OR = 3.7; p = 0.00012) was a higher risk allele for collagen disease in adult patients, and B*13:01 (OR = 23.2; p = 0.021) and C*03:04 (OR = 5.8; p = 0.0074) were higher risk for juvenile patients with anti-HMGCR antibody-positive IMNM. These findings will help to better understand the HLA genetic background and features of IMNM in designing future studies.
KW - disease association
KW - genotyping
KW - HLA
KW - immune-mediated necrotizing myopathy
UR - http://www.scopus.com/inward/record.url?scp=85146340554&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85146340554&partnerID=8YFLogxK
U2 - 10.1111/tan.14950
DO - 10.1111/tan.14950
M3 - Article
C2 - 36565042
AN - SCOPUS:85146340554
SN - 2059-2302
VL - 101
SP - 449
EP - 457
JO - HLA
JF - HLA
IS - 5
ER -